Skip to Content


In the US, Zytiga (abiraterone systemic) is a member of the drug class miscellaneous antineoplastics and is used to treat Prostate Cancer.

US matches:

UK matches:

Ingredient matches for Zytiga


Abiraterone is reported as an ingredient of Zytiga in the following countries:

  • Bosnia & Herzegowina
  • Brazil
  • Cyprus
  • Latvia
  • Lithuania
  • Poland
  • Serbia
  • Tunisia
  • Turkey

Abiraterone acetate (a derivative of Abiraterone) is reported as an ingredient of Zytiga in the following countries:

  • Argentina
  • Australia
  • Belgium
  • Canada
  • Chile
  • Colombia
  • Croatia (Hrvatska)
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Greece
  • Hong Kong
  • Iceland
  • Indonesia
  • Ireland
  • Israel
  • Japan
  • Macedonia
  • Malaysia
  • Netherlands
  • New Zealand
  • Norway
  • Oman
  • Peru
  • Philippines
  • Portugal
  • Romania
  • Singapore
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • Thailand
  • United Kingdom
  • United States
  • Vietnam

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.